Eminent Services Corp

Pharmaceutics International, located in Hunt Valley, MD, is a leading pharmaceutical development and manufacturing company. With a team of experienced scientists and state-of-the-art technologies, they offer a wide range of services, including formulation process development, oral and parenteral drug development, aseptic manufacturing, lyophilization cycle development, and clinical trial manufacturing. Their relentless commitment to optimized product development ensures that they can tackle any formulation challenge and accelerate timelines, all while staying on budget. Proudly offering flexible solutions for solubility and bioavailability enhancement, Pharmaceutics International has extensive scientific expertise in improving the dissolution rate of challenging drugs. They utilize various formulation techniques, such as solid dispersions, nanoparticles, and spray-drying, to enhance the solubility and permeability of drugs. Additionally, their expertise in lyophilization cycle development allows them to de-risk the product development process by studying thermal characteristics and scaling up for GMP manufacturing. Pharmaceutics International is dedicated to providing high-quality pharmaceutical solutions to their partners in the pharmaceutical and biotech industries.Generated from the website

ImQuest Biosciences, Inc., located in Frederick, MD, is a preclinical and infectious disease contract research organization (CRO) specializing in the evaluation of novel pharmaceutical products aimed at treating and preventing viruses, bacteria, cancer, and inflammatory diseases. The company offers a diverse range of services, including comprehensive compound screening, drug target validation, and custom assay development tailored for pharmaceutical and biotechnology clients. With decades of expertise in virology, microbiology, immunology, and oncology, ImQuest provides extensive support for preclinical research and development, utilizing innovative techniques and a robust client portfolio that includes large and mid-sized firms, start-ups, and academic investigators. Their specialty services include antiviral and antimicrobial testing, in vitro toxicology assays, and immune response evaluations to facilitate the development of effective therapeutic solutions. Generated from the website

Incorporated in 1989, Otsuka America Pharmaceutical is a health care company that commercializes its products throughout North America. It offers products under the ABILIFY Tablets1 and PLETAL Tablets2 brands. The company works in collaboration with Bristol-Myers Squibb, which co-develops and co-promotes ABILIFY. Otsuka America Pharmaceutical has also merged with Meretek Diagnostics to form the Meretek Diagnostics Group under the Medical Device Division of OAPI. It focuses on neuroscience, cardiovascular, oncologic and gastrointestinal therapeutic treatments. The company operates Otsuka Maryland Research Institute, which was established as a wholly-owned subsidiary of OAPI to research and develop a variety of health care products. Otsuka America Pharmaceutical is a part of Otsuka Pharmaceutical Group.